Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF



GREY:MDCGF - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Indicatoron Feb 23, 2010 9:55pm
379 Views
Post# 16813258

serious competition using tobacco

serious competition using tobaccoLooks like the US Defense Advanced Research Projects Agency is backing GreenVax/iBio Inc - NOT Medicago!

Damn ... I thought Medicago had seriously locked up their tobacco methods with patents!!!
Maybe this is why the stock has been weak
.

" In December, Medicago Inc. of Quebec City reported positive resultsfor a tobacco-based vaccine for avian flu, or H5N1, which has killedmore than 250 people world-wide. Biotechnology firm VAXX Inc. ofTucson, Ariz., says it soon plans to start a human trial of atobacco-based vaccine for Norwalk norovirus—or "cruise shipvirus"—which causes gastroenteritis in as many as 74 million Americansannually.

GreenVax is one of the more ambitious of the plant-based vaccineprojects. It is partly based on research done at Fraunhofer USA Centerfor Molecular Biotechnology, in a partnership with the biotech firmiBio Inc., both based in Newark, Del.

The Defense Advanced Research Projects Agency—which conductsresearch to protect soldiers from infectious diseases, and also isconcerned about the U.S. capability to react swiftly to a bioterroristattack, among other things—has awarded the consortium $40 million tomake an initial 10 million doses of H1N1 vaccine.

Texas A&M and closely held firm G-Con will together invest afurther $21 million. Details of the project, known as GreenVax, will beannounced Wednesday."

https://2hid.sl.pt


<< Previous
Bullboard Posts
Next >>